scholarly journals Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

2015 ◽  
Vol 106 (11) ◽  
pp. 1561-1567 ◽  
Author(s):  
Kosei Matsue ◽  
Hiromi Iwasaki ◽  
Takaaki Chou ◽  
Kensei Tobinai ◽  
Kazutaka Sunami ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Japanese Patients ◽  
Refractory Multiple Myeloma

Phase I dose escalation study of high dose carfilzomib monotherapy for Japanese patients with relapsed or refractory multiple myeloma

2016 ◽  
Vol 104 (5) ◽  
pp. 596-604 ◽  
Author(s):  
Shinsuke Iida ◽  
Kensei Tobinai ◽  
Masafumi Taniwaki ◽  
Yoshihisa Shumiya ◽  
Toru Nakamura ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase I ◽  
Dose Escalation ◽  
Japanese Patients ◽  
High Dose ◽  
Dose Escalation Study ◽  
Refractory Multiple Myeloma

A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma

2015 ◽  
Vol 103 (1) ◽  
pp. 25-33 ◽  
Author(s):  
Yoshiaki Ogawa ◽  
Michinori Ogura ◽  
Kensei Tobinai ◽  
Kiyoshi Ando ◽  
Tatsuya Suzuki ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase I ◽  
Phase I Study ◽  
Japanese Patients ◽  
Refractory Multiple Myeloma

scholarly journals The Pharmacokinetics of Low-Dose Thalidomide in Japanese Patients with Refractory Multiple Myeloma

2006 ◽  
Vol 29 (11) ◽  
pp. 2331-2334 ◽  
Author(s):  
Rintaro Kamikawa ◽  
Kazuro Ikawa ◽  
Norifumi Morikawa ◽  
Hideki Asaoku ◽  
Koji Iwato ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Low Dose ◽  
Japanese Patients ◽  
Refractory Multiple Myeloma

Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma

2016 ◽  
Vol 105 (4) ◽  
pp. 445-452 ◽  
Author(s):  
Kenshi Suzuki ◽  
Hiroshi Handa ◽  
Takaaki Chou ◽  
Kenichi Ishizawa ◽  
Takatoshi Takubo ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase 1 ◽  
Japanese Patients ◽  
Phase 1 Study ◽  
Refractory Multiple Myeloma

scholarly journals PF623 PHASE 1/2 STUDY OF ISATUXIMAB MONOTHERAPY FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA IN JAPANESE PATIENTS

HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 265 ◽  
Author(s):  
S. Iida ◽  
K. Sunami ◽  
M. Ri ◽  
M. Matsumoto ◽  
C. Shimazaki ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase 1 ◽  
Japanese Patients ◽  
Refractory Multiple Myeloma

Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma

2017 ◽  
Vol 107 (4) ◽  
pp. 460-467 ◽  
Author(s):  
Shinsuke Iida ◽  
Tatsuo Ichinohe ◽  
Atsushi Shinagawa ◽  
Kenshi Suzuki ◽  
Naoki Takezako ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Japanese Patients ◽  
Safety And Efficacy ◽  
Refractory Multiple Myeloma
Sign in / Sign up

Export Citation Format

Share Document